Metrion Biosciences

Metrion Biosciences is a specialist preclinical drug discovery CRO - your trusted partner for ion channel screening, cardiac safety screening and neuroscience assays. We provide our customers with a range of in vitro screening services, including cardiac safety (GLP hERG, CiPA panel of human cardiac ion channels) and neurotoxicology testing and phenotypic assays on a fee-for-service or collaboration basis. We pride ourselves on being able to provide a flexible and cost effective service with an unparalleled level of expertise. Collectively, we have 250 years experience managing ion channel research programmes

Ion channels,contract research (cro),ion channel screening,assay development,automated patch clamp,herg testing,cardiac safety assessment,ion channel assays,manual patch clamp,neuroscience,pain assays,phenotypic assays,cipa,drug discovery,and glp herg screening

Metrion biosciences operates in the Research services industry.

Metrion biosciences's revenue is 11m - 100m

Metrion biosciences has 11 - 50 employees.